Net Change In Cash - Theriva Biologics Inc (F:SFY) - Alpha Spread

Theriva Biologics Inc
F:SFY

Watchlist Manager
Theriva Biologics Inc Logo
Theriva Biologics Inc
F:SFY
Watchlist
Price: 2.42 EUR Market Closed
Market Cap: 41.8m EUR
Have any thoughts about
Theriva Biologics Inc?
Write Note

Theriva Biologics Inc
Net Change in Cash

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Theriva Biologics Inc
Net Change in Cash Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Net Change in Cash Analysis
Latest Figures & CAGR of Competitors

Company Net Change in Cash CAGR 3Y CAGR 5Y CAGR 10Y
Theriva Biologics Inc
F:SFY
Net Change in Cash
-$17.8m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Abbvie Inc
NYSE:ABBV
Net Change in Cash
$4.4B
CAGR 3-Years
20%
CAGR 5-Years
22%
CAGR 10-Years
29%
Gilead Sciences Inc
NASDAQ:GILD
Net Change in Cash
-$2.9B
CAGR 3-Years
-17%
CAGR 5-Years
-8%
CAGR 10-Years
N/A
Amgen Inc
NASDAQ:AMGN
Net Change in Cash
-$24.9B
CAGR 3-Years
-115%
CAGR 5-Years
-40%
CAGR 10-Years
-33%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Net Change in Cash
-$5.6B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-48%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Net Change in Cash
-$21.5m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Theriva Biologics Inc's Net Change in Cash?
Net Change in Cash
-17.8m USD

Based on the financial report for Mar 31, 2024, Theriva Biologics Inc's Net Change in Cash amounts to -17.8m USD.

What is Theriva Biologics Inc's Net Change in Cash growth rate?
Net Change in Cash CAGR 1Y
14%

Over the last year, the Net Change in Cash growth was 14%.

Back to Top